Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders

被引:16
|
作者
Gabilondo, Inigo [1 ,2 ]
Llorens, Veronica [1 ,3 ]
Rodriguez, Trinidad [3 ]
Fernandez, Manuel [1 ,2 ,4 ]
Perez Concha, Tomas [2 ]
Acera, Marian [1 ]
Tijero, Beatriz [1 ,2 ]
Murueta-Goyena, Ane [1 ]
del Pino, Rocio [1 ]
Cortes, Jesus [5 ,6 ,7 ]
Carlos Gomez-Esteban, Juan [1 ,2 ,4 ]
机构
[1] Biocruces Bizkaia Hlth Res Inst, Neurodegenerat Dis Grp, Plaza Cruces 12, Baracaldo 48903, Bizkaia, Spain
[2] Cruces Univ Hosp, Dept Neurol, Baracaldo, Bizkaia, Spain
[3] Cruces Univ Hosp, Dept Nucl Med, Baracaldo, Bizkaia, Spain
[4] Univ Basque Country UPV EHU, Dept Neurosci, Leioa, Spain
[5] Biocruces Bizkaia Hlth Res Inst, Computat Neuroimaging Grp, Baracaldo, Bizkaia, Spain
[6] Ikerbasque Basque Fdn Sci, Bilbao, Spain
[7] Univ Basque Country UPV EHU, Dept Cell Biol & Histol, Leioa, Spain
关键词
Parkinson's disease; MIBG cardiac scintigraphy; Dysautonomia; Genetic; Alpha-synuclein; I-123-MIBG CARDIAC SCINTIGRAPHY; I-123-METAIODOBENZYLGUANIDINE; MUTATION; DENERVATION; DEMENTIA; CARRIERS; E46K;
D O I
10.1007/s00259-018-4183-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeTo identify myocardial sympathetic denervation patterns suggestive of Lewy body (LB) pathology in patients with genetic and idiopathic parkinsonisms by I-123-metaiodobenzylguanidine (MIBG) scintigraphy.MethodsWe retrospectively analysed myocardial MIBG images acquired with a dual-head gamma camera and low-energy high-resolution collimator (LEHR) in 194 patients with suspected synucleinopathy or atypical parkinsonism, including 34 with genetic Parkinson's disease (PD; 4 PARK1, 8 PARK2 and 22 PARK8), 85 with idiopathic PD (iPD), 6 with idiopathic REM sleep behaviour disorder (iRBD), 17 with dementia with LB (DLB), 40 with multiple system atrophy (MSA) and 12 with progressive supranuclear palsy (PSP), and in 45 healthy controls. We calculated heart-to-mediastinum MIBG uptake ratios (HMR) at 15min and 4h (HMR4H) for the LEHR and standardized medium-energy collimators, to obtain classification accuracies and optimal cut-off values for HMR using supervised classification and ROC analyses.ResultsWhile patients with LB disorders had markedly lower HMR4H(LEHR) than controls (controls 1.860.26, iPD 1.38 +/- 0.29, iRBD 1.23 +/- 0.09, PARK1 1.20 +/- 0.09, DLB 1.17 +/- 0.11; p<0.05), for the remaining patient categories differences were smaller (PARK8 1.51 +/- 0.32; p<0.05) or not significant (MSA 1.82 +/- 0.37, PSP 1.59 +/- 0.23, PARK2 1.51 +/- 0.30; p>0.05). The diagnostic accuracy of HMR4H(LEHR) was highest in patients with LB disorders (PARK1, iPD, DLB, iRBD; 89% to 97%) and lowest in those with PARK2, PARK8, PSP and MSA (65% to 76%), with an optimal HMR4H(LEHR) cut-off value of 1.72 for discriminating most patients with LB disorders including iPD and 1.40 for discriminating those with aggressive LB spectrum phenotypes (DLB, PARK1 and iRBD).Conclusion Our study including patients with a wide spectrum of genetic and idiopathic parkinsonisms with different degrees of LB pathology further supports myocardial MIBG scintigraphy as an accurate tool for discriminating patients with LB spectrum disorders.
引用
收藏
页码:376 / 384
页数:9
相关论文
共 50 条
  • [21] Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy
    Nagamachi, Shigeki
    Wakamatsu, Hideyuki
    Kiyohara, Shogo
    Fujita, Seigo
    Futami, Shigemi
    Tamura, Shozo
    Nakazato, Masamitsu
    Yamashita, Syuichi
    Arita, Hideo
    Nishii, Ryuichi
    Kawai, Keiichi
    ANNALS OF NUCLEAR MEDICINE, 2008, 22 (07) : 557 - 564
  • [22] Correlation of heart rate variability analysis and MIBG myocardial scintigraphy in patients with Parkinson's disease
    Nakahara, Keiichi
    Nakane, Shunya
    Ando, Yukio
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 : 146 - 147
  • [23] Lewy Body Spectrum Disorders: from Dementia with Lewy Bodies to Parkinson’s Disease Dementia
    Redden W.
    Bheemisetty S.
    Current Geriatrics Reports, 2016, 5 (4) : 252 - 258
  • [24] Usefulness of rCBF analysis in diagnosing Parkinson’s disease: supplemental role with MIBG myocardial scintigraphy
    Shigeki Nagamachi
    Hideyuki Wakamatsu
    Shogo Kiyohara
    Seigo Fujita
    Shigemi Futami
    Shozo Tamura
    Masamitsu Nakazato
    Syuichi Yamashita
    Hideo Arita
    Ryuichi Nishii
    Keiichi Kawai
    Annals of Nuclear Medicine, 2008, 22 : 557 - 564
  • [25] Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson's disease
    Boccalini, Cecilia
    Carli, Giulia
    Vanoli, Emilia Giovanna
    Cocco, Antoniangela
    Albanese, Alberto
    Garibotto, Valentina
    Perani, Daniela
    FRONTIERS IN MEDICINE, 2022, 9
  • [26] Myocardial scintigraphy with 123I MIBG in a patient with Parkinson's
    Sadeck, G.
    Lavatori, N.
    Palazzo, I.
    Veras, M.
    Sabra, M.
    Correa, F.
    Cotrado, A.
    Aguiar, W. K.
    Ker, W.
    Andre, C.
    Tinoco, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S570 - S570
  • [27] Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy
    Matsui, H
    Udaka, F
    Oda, M
    Kubori, T
    Nishinaka, K
    Kameyama, M
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2005, 119 (01): : 56 - 60
  • [29] Optimal Protocol and Clinical Usefulness of 123I-MIBG Cardiac Scintigraphy for Differentiation of Parkinson’s Disease and Dementia with Lewy Body from Non-Parkinson’s Diseases
    In Kook Chun
    Nuclear Medicine and Molecular Imaging, 2023, 57 : 145 - 154
  • [30] Myocardial 123I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD
    Novellino, Fabiana
    Bagnato, Antonio
    Salsone, Maria
    Cascini, Giuseppe Lucio
    Nicoletti, Giuseppe
    Arabia, Gennarina
    Pugliese, Pierfrancesco
    Morelli, Maurizio
    Paglionico, Sandra
    Cipullo, Stefania
    Manna, Ida
    De Marco, Elvira Valeria
    Condino, Francesca
    Chiriaco, Carmelina
    Morgante, Letterio
    Zappia, Mario
    Quattrone, Aldo
    NEUROBIOLOGY OF AGING, 2010, 31 (11) : 1903 - 1911